Codon 91 gyrase a testing is necessary and sufficient to predict ciprofloxacin susceptibility in neisseria gonorrhoeae

Journal of Infectious Diseases

Volumn 215, Issue 3, 2017, Pages 491-

  Allan Blitz, Lao Tzu ^a   Klausner, Jeffrey D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CEFTRIAXONE; CIPROFLOXACIN; GYRASE A; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; CLINICAL PRACTICE; CODON; DRUG USE; GENE MUTATION; GENOTYPE; GYRA GENE; LETTER; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENETICS; GENOMICS; GONORRHEA; HUMAN; UNITED STATES;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CIPROFLOXACIN; CODON; FLUOROQUINOLONES; GENOMICS; GONORRHEA; HUMANS; MACROLIDES; NEISSERIA GONORRHOEAE; UNITED STATES;

EID: 85019961234     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw551     Document Type: Letter

References (10)

1. Grad YH, Harris SR, Kirkcaldy RD, et al. Genomic epidemiology of gonococcal resistance to extended spectrum cephalosporins, macrolides, and fluoroquinolones in the United States, 2000-2013. J Infect Dis 2016; 214:1579-87.
2. Hemarajata P, Yang S, Soge OO, Humphries RM, Klausner JD. Performance and verification of a real-time PCR assay targeting the gyrA gene for prediction of ciprofloxacin resistance in Neisseria gonorrhoeae. J Clin Microbiol 2016; 54:805-8.
3. Dona V, Kasraian S, Lupo A, et al. Multiplex realtime PCR assay with high-resolution melting analysis for characterization of antimicrobial resistance in Neisseria gonorrhoeae. J Clin Microbiol 2016; 54:2074-81.
4. Peterson SW, Martin I, Demczuk W, et al. Molecular assay for detection of ciprofloxacin resistance in Neisseria gonorrhoeae isolates from cultures and clinical nucleic acid amplification test specimens. J Clin Microbiol 2015; 53:3606-8.
5. Zhao L, Zhao S. TaqMan real-time quantitative PCR assay for detection of fluoroquinolone-resistant Neisseria gonorrhoeae. Curr Microbiol 2012; 65:692-5.
6. Siedner MJ, Pandori M, Castro L, et al. Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples. J Clin Microbiol 2007; 45:1250-4.
7. Kulkarni S, Bala M, Sane S, Pandey S, Bhattacharya J, Risbud A. Mutations in the gyrA and parC genes of quinolone-resistant Neisseria gonorrhoeae isolates in India. Int J Antimicrob Agents 2012; 40:549-53.
8. Kirkcaldy RD, Harvey A, Papp JR, et al., Neisseria gonorrhoeae antimicrobial susceptibility surveillance-the Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014. MMWR Surveill Summ 2016. 65:1-19.
9. Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 2014; 27:587-613.
10. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Atlanta, Ga: Centers for Disease Control and Prevention, 2013.